Receptos, Inc. is a biopharmaceutical company. It develops therapeutic for the treatment of immune and metabolic diseases. Receptos, Inc. is headquartered in San Diego, California.
technical indicators:
- 100% Barchart technical buy signals
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 8 new highs and up 31.32% in the last month
- Relative Strength Index 75.56%
- Barchart computes a technical support level at 192.71
- Recently traded at 229.81 with a 50 day moving average of 174.71
Fundamental factors:
- Market Cap $7.25 billion
- Revenue expected to grow 272.20% this year and another 58.60% next year
- Earnings estimated to decrease 9.70% this year an an additional 13.80% next year
- In spite of the poor earnings projections the stock keeps rising and Wall Street analysts issued 2 strong buy and 4 buy recommendations on the stock
The 20-100 Day MACD Oscillator has been a reliable technical trading strategy for this stock
No comments:
Post a Comment